Clinical Trial Update: Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

A Phase 2 trial of intensive chemotherapy with or without volasertib in newly diagnosed high-risk myelodysplastic syndrome and acute myeloid leukemia was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Volasertib (Volasertib)

Snippet

Sponsor: University of Ulm | Conditions: Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) | Phase 2 | Status: TERMINATED